Why can't we develop COVID-19 treatments faster?

• Authors : KOMAROFF, ANTHONY L.

Subjects: ANTIVIRAL agents; DRUG efficacy; MEDICAL emergencies

• Source: Harvard Health Letter. Sep2020, Vol. 45 Issue 11, p2-2. 3/4p. 1 Color Photograph.

• Abstract: The article presents answer to the question related to COVID-19 is an unprecedented public health

Record details

ETHICS OF CLINICAL SCIENCE IN A PUBLIC HEALTH EMERGENCY: DRUG DISCOVERY AT THE BEDSIDE.

• Authors : EDWARDS, SARAH J. L.¹

Subjects: *PUBLIC health; *COVID-19 pandemic; *MEDICAL emergenciesUNITED States. Food & Drug Administration ; WORLD Health Organization

• Source: Current. Nov2013, Issue 557, p3-12. 10p.

• Abstract: Clinical research under the usual regulatory constraints may be difficult or even impossible in a public health Copyright of Current is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted ...

Record details

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.

• Authors : Panlilio AL; Cardo DM; Grohskopf LA

• Source: MMWR: Morbidity & Mortality Weekly Report (MMWR MORB MORTAL WKLY REP), 9/30/2005; 54(38): 1-17. (17p)

Record details

Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy. Public Health Service statement.

• Authors : US Department of Health and Human Services. Centers for Disease Control and Prevention

• Source: MMWR: Morbidity & Mortality Weekly Report (MMWR MORB MORTAL WKLY REP), 9/25/1998 Supplement RR-17; 47(37): 1-14. (14p)

Record details

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States [corrected] [published erratum appears in MMWR MORB MORTAL WKLY REP 2002 Nov 29;51(47):1075].

• Authors : Mofenson LM; US Department of Health and Human Services. Centers for Disease Control and Prevention

• Source: MMWR: Morbidity & Mortality Weekly Report (MMWR MORB MORTAL WKLY REP), 11/22/2002 Supplement SS-8; 51(46): 1-1. (38p)

Record details

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis.

• Authors : Beltrami EM; Alvarado-Ramy F; Critchley SE ...

• Source: MMWR: Morbidity & Mortality Weekly Report (MMWR MORB MORTAL WKLY REP), 6/29/2001; 50(25): 1-7. (52p)

Record details

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

• Authors : Smith NM; Bresee JS; Shay DK

• Source: MMWR: Morbidity & Mortality Weekly Report (MMWR MORB MORTAL WKLY REP), 7/28/2006; 55(29): 1-41. (41p)

Record details

Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing HIV-1 transmission in the United States.

• Authors : US Department of Health and Human Services. Centers for Disease Control and Prevention

• Source: MMWR: Morbidity & Mortality Weekly Report (MMWR MORB MORTAL WKLY REP), 1/30/1998 Supplement RR-2; 47(3): 1-30. (30p)

Record details

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices -- United States, 2013-2014.

• Source: MMWR Recommendations & Reports (MMWR RECOMM REP), 9/20/2013; 62(7): 1-42. (42p)

Record details

Salicinium® Treats and Prevents Cancer and Viral Infections.

• Authors : King, Jeffrey J.

Subjects: BENZALDEHYDE; ANTINEOPLASTIC agents; ANTIVIRAL agents

• Source: Townsend Letter. Aug/Sep2019, Issue 433/434, p42-50. 8p.

• Abstract: This article describes a long-term, multi-site study demonstrating potent anti-cancer and antiviral effects of glyco-benzaldehydes and related compounds developed under the ... Copyright of Townsend Letter is the property of Townsend Letter Group and its content may not be copied or emailed to multiple sites or ...

Record details